Eight new homes for first-time buyers

Here’s a round-up of some of the best houses available via schemes that offer some form of help for first-time buyers

Spero Therapeutics, Inc. (SPRO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

1.3800

-0.0600

(-4.17%)

At close: 04:00PM EDT

1.3900

+0.01

(+0.72%)

After hours:

07:34PM EDT

Currency in USD

Earnings estimate	Current qtr. (Mar 2022)	Next qtr. (Jun 2022)	Current year (2022)	Next year (2023)
No. of analysts	3	3	5	4
Avg. Estimate	-0.87	-0.66	-2.78	-2.02
Low estimate	-1	-0.84	-3.79	-2.39
High estimate	-0.8	-0.55	-1.88	-1.17
Year ago EPS	-0.66	-0.63	-2.91	-2.78

Revenue estimate	Current qtr. (Mar 2022)	Next qtr. (Jun 2022)	Current year (2022)	Next year (2023)
No. of analysts	3	3	4	2
Avg. Estimate	2.57M	2.6M	18.83M	128.44M
Low estimate	2M	2M	8M	81M
High estimate	3M	3M	36M	175.89M
Year ago sales	7.3M	5.15M	18.26M	18.83M
Sales growth (year/est)	-64.80%	-49.50%	3.10%	582.10%

Earnings history	30/03/2021	29/06/2021	29/09/2021	30/12/2021
Est. EPS	-0.64	-0.75	-0.66	-0.75
Actual EPS	-0.66	-0.63	-0.7	-0.9
Difference	-0.02	0.12	-0.04	-0.15
Surprise %	-3.10%	16.00%	-6.10%	-20.00%

EPS trend	Current qtr. (Mar 2022)	Next qtr. (Jun 2022)	Current year (2022)	Next year (2023)
Current estimate	-0.87	-0.66	-2.78	-2.02
7 days ago	-0.87	-0.75	-3.06	-2.02
30 days ago	-0.89	-0.93	-3.46	-1.72
60 days ago	-1.06	-1.12	-3.51	-1.39
90 days ago	-1.06	-1.12	-3.51	-1.39

EPS revisions	Current qtr. (Mar 2022)	Next qtr. (Jun 2022)	Current year (2022)	Next year (2023)
Up last 7 days	N/A	1	1	1
Up last 30 days	1	3	3	1
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	N/A	N/A	N/A	1

Growth estimates	SPRO	Industry	Sector(s)	S&P 500
Current qtr.	-31.80%	N/A	N/A	N/A
Next qtr.	-4.80%	N/A	N/A	N/A
Current year	4.50%	N/A	N/A	N/A
Next year	27.30%	N/A	N/A	N/A
Next 5 years (per annum)	36.90%	N/A	N/A	N/A
Past 5 years (per annum)	N/A	N/A	N/A	N/A